Inactive Instrument
Checkmate Pharmaceuticals, Inc. Share Price
Stocks
CMPI
US1628181083
Biotechnology & Medical Research
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 62 | 11/12/2018 | |
Robert Landry
DFI | Director of Finance/CFO | 62 | 30/05/2022 |
James Wooldridge
CTO | Chief Tech/Sci/R&D Officer | 60 | 30/09/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Nouhad Husseini
BRD | Director/Board Member | - | 30/05/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 30/05/22 | Issuer sale | Director | 36,778 | 0.1700% | ||
| 30/05/22 | Issuer sale | Director | 30,030 | 0.1388% | ||
| 30/05/22 | Issuer sale | Director | 20,061 | 0.0927% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +0.38% | - | - | 231M | |
| +1.03% | +7.52% | +54.74% | +114.98% | 55.58B | |
| +2.72% | +3.06% | +53.28% | +47.85% | 43.47B | |
| +1.12% | +1.06% | -14.15% | -17.13% | 22.64B | |
| +1.17% | -6.74% | -0.13% | +394.19% | 20.96B | |
| +3.81% | -4.13% | +16.62% | -30.70% | 15.79B | |
| +0.15% | +2.24% | +9.06% | -39.50% | 15.3B | |
| -0.69% | +1.22% | +28.24% | +176.72% | 13.45B | |
| +5.27% | +6.41% | +21.05% | - | 11.74B | |
| +1.61% | +1.17% | +90.79% | +212.97% | 10.96B | |
| Average | +1.62% | +0.26% | +28.83% | +107.42% | 23.32B | |
| Weighted average by Cap. | +1.70% | +1.60% | +33.63% | +100.77% |
Employees
31
